Mastering the PSMF: The Pillar of Inspection Readiness for MAHs,
LPPVs & QPPVs
Explore the critical role of the PSMF and learn how MAHs, LPPVs, and QPPVs can drive inspection
readiness through strong governance and regulatory alignment.
Date: March 12, 2026
Time: 10:00-11:00 AM US EST / 3:00-4:00 PM CET
About the Webinar
First impressions are everything, especially during a pharmacovigilance (PV) inspection. As the inspector’s primary entry point into an organisation’s PV system, the Pharmacovigilance System Master File (PSMF) is a critical demonstration of a Marketing Authorisation Holder’s governance, oversight, and commitment to patient safety, and can be leveraged to showcase continuous improvement in key areas.
For MAHs, the PSMF provides a transparent view of how PV responsibilities are structured, maintained, and overseen by the LPPV/QPPV. When effectively managed, it not only meets regulatory expectations but also evidences robust oversight, continuous improvement, and inspection readiness across the PV system.
Using real-world examples and practical insights, this webinar will explore how the PSMF is assessed during PV inspections, common inspection findings, and how MAHs and LPPVs/QPPVs can proactively anticipate and address inspector expectations.
By adopting a strategic approach to PSMF ownership and maintenance, organisations can transform this regulatory requirement into a powerful tool that reinforces accountability, compliance, and patient safety — setting the right tone from the very first inspection interaction.
What You’ll Learn
- The role of the EEA / UK PSMF during Pharmacovigilance Inspections
- MAH responsibilities and expectations for PSMF governance and oversight
- The role of the LPPV/QPPV in ensuring PSMF accuracy, compliance, and inspection readiness
- Examples of real-world PSMF inspection findings and regulatory observations
- Best practices for avoiding PSMF findings and demonstrating effective oversight
Who Should Attend
- Marketing Authorisation Holders (MAHs)
- LPPVs / QPPVs and Deputy QPPVs
- Pharmacovigilance professionals across all PV functions
- Quality, compliance, and governance stakeholders involved in PSMF maintenance
The PSMF impacts everyone—and effective MAH and LPPV/QPPV oversight is central to its success.
Unable to join? Register and you will receive the recording after the live session.
Meet the Speakers
-
David Lough
Senior Pharmacovigilance Consultant, QPPV Office
View Bio
David Lough
David has been working in Pharmacovigilance Consulting for the past 8 years and has held the roles of EU QPPV, UK QPPV and UK NCP. David is an expert on the creation and management of marketing authorisation holder PV systems. Within ProPharma, David is the PSMF SME and has been responsible for the coordination, creation and/or maintenance of around 30 client PSMFs. As the PSMF SME, David is often involved in client audits and inspections and has used this exposure to continuously improve and update ProPharma’s PSMF creation and maintenance process.